1. Home
  2. FR vs KNSA Comparison

FR vs KNSA Comparison

Compare FR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Industrial Realty Trust Inc.

FR

First Industrial Realty Trust Inc.

SELL

Current Price

$54.65

Market Cap

7.7B

Sector

Real Estate

ML Signal

SELL

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

SELL

Current Price

$94.87

Market Cap

7.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FR
KNSA
Founded
1993
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
7.7B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
FR
KNSA
Price
$54.65
$94.87
Analyst Decision
Buy
Strong Buy
Analyst Count
17
7
Target Price
$64.38
★ $111.57
AVG Volume (30 Days)
★ 1.8M
883.3K
Earning Date
10-21-2026
10-27-2026
Dividend Yield
★ 3.64%
N/A
EPS Growth
N/A
★ 225.00
EPS
★ 1.66
1.14
Revenue
★ $727,076,000.00
$677,564,000.00
Revenue This Year
$8.45
$54.80
Revenue Next Year
$6.13
$28.50
P/E Ratio
★ $33.11
$82.69
Revenue Growth
8.58
★ 60.09
52 Week Low
$53.27
$37.02
52 Week High
$69.88
$99.31

Technical Indicators

Market Signals
Indicator
FR
KNSA
Relative Strength Index (RSI) 37.10 57.19
Support Level $53.27 $87.30
Resistance Level $64.27 $98.90
Average True Range (ATR) 0.95 4.44
MACD 0.20 -0.19
Stochastic Oscillator 39.19 58.03

Price Performance

Historical Comparison
FR
KNSA

About FR First Industrial Realty Trust Inc.

First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: